Vertex Energy Chief Operating Officer James Rhame to Retire-May 2024-www.financetom.com

Vertex Energy Chief Operating Officer James Rhame to Retire

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Vertex Energy Chief Operating Officer James Rhame to Retire

Jul 18, 2024 2:11 AM

04:46 AM EDT, 07/18/2024 (MT Newswires) -- Vertex Energy ( VTNR ) said late Wednesday its Chief Operating Officer James Rhame will retire from his position, effective July 25.

The company has appointed Chief Commercial Officer Doug Haugh as interim chief operating officer.

Rhame will continue in a consulting role at Vertex through the end of 2024, the company said.

Previous page： Market Chatter: Microsoft-Backed OpenAI, Bain Expand Partnership to Sell AI Tools to Bain Clients Next page： Greenheart Gold Up 9.2% as it Completes a $36 Million Private Placement

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: Microsoft-Backed OpenAI, Bain Expand Partnership to Sell AI Tools to Bain Clients

Oct 17, 2024

02:44 PM EDT, 10/17/2024 (MT Newswires) -- Microsoft ( MSFT )-backed (MSFT) OpenAI and Bain are extending their partnership to sell OpenAI's ChatGPT and other AI tools to the consulting firm's clients, The Wall Street Journal reported Thursday. The companies started a sales partnership in 2023 and in August 13,000 Bain consultants got licenses for ChatGPT Enterprise, according to the...

Greenheart Gold Up 9.2% as it Completes a $36 Million Private Placement

Oct 17, 2024

02:31 PM EDT, 10/17/2024 (MT Newswires) -- Greenheart Gold ( GHRTF ) on Thursday said it closed a brokered private placement financing that raised $36 million as it placed 72.09-million shares priced at $0.50 each. Proceeds will be used to acquire properties mineral properties in Guyana and Suriname, for working capital and general corporate purposes. Greenheart Gold ( GHRTF )...

Immutep Completes Recruitment for Early-Stage Trial of IMP761, Advances to Dose Escalation

Oct 17, 2024

09:07 AM EDT, 10/17/2024 (MT Newswires) -- Immutep ( IMMP ) said Thursday that it has completed recruitment for the first part of its early-stage trial for IMP761, a LAG-3 immunotherapy aimed at treating autoimmune diseases. The part A, single dose, of the placebo-controlled, double-blind trial reported no safety issues following drug administration, the company said. The trial will now...

Kezar Life Sciences Gets Nod to Proceed With Autoimmune Hepatitis Trial; Ends Lupus Nephritis Study

Oct 17, 2024

02:44 PM EDT, 10/17/2024 (MT Newswires) -- Kezar Life Sciences ( KZR ) said Thursday the Independent Data Monitoring Committee has recommended the Portola phase 2a trial of zetomipzomib in patients with autoimmune hepatitis to proceed without modification following its review. Kezar said the trial, which is being conducted in the US, has so far not shown any grade 4...